Clinical Trial Detail

NCT ID NCT01398462
Title Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors JW Pharmaceutical
Indications

acute myeloid leukemia

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

Therapies

CWP232291

Age Groups: adult

Additional content available in CKB BOOST